File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Long-term outcome of aortofemoral bypass for aortoiliac occlusive disease

TitleLong-term outcome of aortofemoral bypass for aortoiliac occlusive disease
Authors
KeywordsAortofemoral bypass
Claudication
Peripheral vascular disease
Vascular
Issue Date2000
PublisherAcademy of Medicine Singapore. The Journal's web site is located at http://www.annals.edu.sg
Citation
Annals Of The Academy Of Medicine Singapore, 2000, v. 29 n. 4, p. 434-438 How to Cite?
AbstractIntroduction: Revascularisation of aortoiliac occlusive disease has been evolving in the past 2 decades. The present study was undertaken to evaluate the long-term outcomes of aortofemoral bypass for aortoiliac occlusive disease at a tertiary vascular disease centre in Hong Kong. Materials and Methods: A retrospective analysis of 94 patients (176 limbs) who survived aortofemoral bypass was performed to evaluate the graft patency, long-term complications, limb loss and patient survival rates. Thirty-six patients were operated for incapacitating claudication (Group I) and 58 for limb salvage (Group II). Results: The overall primary patency rates of aortofemoral bypass were 97%, 90%, 89% and 84% at 1, 3, 5 and 10 years, respectively. Poor distal run-off and neointimal hyperplasia were the leading causes of late graft failure. Other late complications included femoral pseudoaneurysm (n = 1), infection (n = 1) and femoral graft aneurysms (n = 2). The limb loss rate was 5.1% at 4 years. The overall survival rates were 95%, 86%, 81% and 75% at 1, 3, 5 and 10 years, respectively. Ischaemic heart disease and malignancy were the 2 major causes of late death. The 5-year survival rate of group I patients (96%) was significantly superior to that of group II patients (70%). Conclusions: Aortofemoral bypass achieved a primary patency rate of 89% at 5 years and a satisfactory limb salvage rate. It remains the preferred treatment option for good risk patients with complete occlusion or extensive stenosis of the aortoiliac arteries.
Persistent Identifierhttp://hdl.handle.net/10722/83467
ISSN
2022 Impact Factor: 5.2
2023 SCImago Journal Rankings: 0.383
References

 

DC FieldValueLanguage
dc.contributor.authorLau, Hen_HK
dc.contributor.authorCheng, SWKen_HK
dc.date.accessioned2010-09-06T08:41:23Z-
dc.date.available2010-09-06T08:41:23Z-
dc.date.issued2000en_HK
dc.identifier.citationAnnals Of The Academy Of Medicine Singapore, 2000, v. 29 n. 4, p. 434-438en_HK
dc.identifier.issn0304-4602en_HK
dc.identifier.urihttp://hdl.handle.net/10722/83467-
dc.description.abstractIntroduction: Revascularisation of aortoiliac occlusive disease has been evolving in the past 2 decades. The present study was undertaken to evaluate the long-term outcomes of aortofemoral bypass for aortoiliac occlusive disease at a tertiary vascular disease centre in Hong Kong. Materials and Methods: A retrospective analysis of 94 patients (176 limbs) who survived aortofemoral bypass was performed to evaluate the graft patency, long-term complications, limb loss and patient survival rates. Thirty-six patients were operated for incapacitating claudication (Group I) and 58 for limb salvage (Group II). Results: The overall primary patency rates of aortofemoral bypass were 97%, 90%, 89% and 84% at 1, 3, 5 and 10 years, respectively. Poor distal run-off and neointimal hyperplasia were the leading causes of late graft failure. Other late complications included femoral pseudoaneurysm (n = 1), infection (n = 1) and femoral graft aneurysms (n = 2). The limb loss rate was 5.1% at 4 years. The overall survival rates were 95%, 86%, 81% and 75% at 1, 3, 5 and 10 years, respectively. Ischaemic heart disease and malignancy were the 2 major causes of late death. The 5-year survival rate of group I patients (96%) was significantly superior to that of group II patients (70%). Conclusions: Aortofemoral bypass achieved a primary patency rate of 89% at 5 years and a satisfactory limb salvage rate. It remains the preferred treatment option for good risk patients with complete occlusion or extensive stenosis of the aortoiliac arteries.en_HK
dc.languageengen_HK
dc.publisherAcademy of Medicine Singapore. The Journal's web site is located at http://www.annals.edu.sgen_HK
dc.relation.ispartofAnnals of the Academy of Medicine Singaporeen_HK
dc.subjectAortofemoral bypassen_HK
dc.subjectClaudicationen_HK
dc.subjectPeripheral vascular diseaseen_HK
dc.subjectVascularen_HK
dc.titleLong-term outcome of aortofemoral bypass for aortoiliac occlusive diseaseen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0304-4602&volume=29&spage=434&epage=438&date=2000&atitle=Long-term+outcome+of+aortofemoral+bypass+for+aortoiliac+occlusive+diseaseen_HK
dc.identifier.emailCheng, SWK: wkcheng@hkucc.hku.hken_HK
dc.identifier.authorityCheng, SWK=rp00374en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.pmid11056770en_HK
dc.identifier.scopuseid_2-s2.0-0034231889en_HK
dc.identifier.hkuros59873en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0034231889&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume29en_HK
dc.identifier.issue4en_HK
dc.identifier.spage434en_HK
dc.identifier.epage438en_HK
dc.publisher.placeSingaporeen_HK
dc.identifier.scopusauthoridLau, H=7201497812en_HK
dc.identifier.scopusauthoridCheng, SWK=7404684779en_HK
dc.identifier.issnl0304-4602-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats